APA (7th ed.) Citation

Rider, D., Chivers, S., Aretz, J., Eisermann, M., Löffler, K., Hauptmann, J., . . . Campion, G. (2022). Preclinical Toxicological Assessment of A Novel siRNA, SLN360, Targeting Elevated Lipoprotein (a) in Cardiovascular Disease. Toxicological Sciences, 189(2), 237. https://doi.org/10.1093/toxsci/kfac067

Chicago Style (17th ed.) Citation

Rider, David, Simon Chivers, Julia Aretz, Mona Eisermann, Kathrin Löffler, Judith Hauptmann, Eliot Morrison, and Giles Campion. "Preclinical Toxicological Assessment of A Novel SiRNA, SLN360, Targeting Elevated Lipoprotein (a) in Cardiovascular Disease." Toxicological Sciences 189, no. 2 (2022): 237. https://doi.org/10.1093/toxsci/kfac067.

MLA (9th ed.) Citation

Rider, David, et al. "Preclinical Toxicological Assessment of A Novel SiRNA, SLN360, Targeting Elevated Lipoprotein (a) in Cardiovascular Disease." Toxicological Sciences, vol. 189, no. 2, 2022, p. 237, https://doi.org/10.1093/toxsci/kfac067.